Why are ResMed (RMD) shares falling?
RMD -4.43%: Has been weak following their quarterly update on Thursday with underlying revenue growth flat plus they also saw contracting margins which is not a good look. Higher costs and product mix was to blame however it was clearly a weak update and trends here are soft. . Buyers have stepped up into weakness which is customary in such a high quality name like RMD, however it feels to us that the ‘buy the dip’ for RMD is losing some of its appeal today.
MM are neutral RMD
Add To Hit List
